Home 5 Lab Industry Report 5 FDA-lir 5 FDA Watch: Greenlights for NGS Tumor Panels May Augur New Approach to LDT Approvals—Both Product & Pathway

FDA Watch: Greenlights for NGS Tumor Panels May Augur New Approach to LDT Approvals—Both Product & Pathway

by | Jan 16, 2018

From - Laboratory Industry Report A pair of tumor tests highlights the list of new FDA approvals from mid-November through December, including… . . . read more

This content is exclusive to Lab Industry Report subscribers

Start a Free Triall for immediate access to this article and our entire archive of over 20 years of LIR reports.